Accès ouvert

Retraction Note: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial

Article scientifique 2021 Anglais

Résumé

After concerns were brought to the Editors' attention after publication, the raw data underlying the study were requested. The authors provided several versions of their dataset. Post-publication peer review confirmed that none of these versions fully recapitulates the results presented in the cohort background comparisons, casting doubt on the reliability of the data. Additional concerns were raised about the randomisation procedure, as the equal distribution of male and female patients is unlikely unless sex is a parameter considered during randomisation. However, based on the clarification provided by the authors, sex was not considered during this process. The Editors therefore no longer have confidence in the results and conclusions presented.

Citer ce document

Dabbous, H., El‐Sayed, M., Assal, G., Elghazaly, H., Ebeid, F., Sherief, A., Fawzy, E., Hassany, S., Riad, A., Tageldin, M. (2021). Retraction Note: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial. https://doi.org/10.1038/s41598-021-98683-5

Accès au document

Voir sur le dépôt source

Ce document est hébergé sur son dépôt institutionnel d'origine.

Auteur(s)

Hany Dabbous Manal H. El‐Sayed Gihan El Assal Hesham Elghazaly Fatma Soliman Elsayed Ebeid Ahmed F. Sherief Ehab Fawzy Sahar M. Hassany Ahmed R. Riad Mohamed Awad Tageldin

Statistiques

Consultations : 1

Téléchargements : 0